JPWO2023081722A5 - - Google Patents
Info
- Publication number
- JPWO2023081722A5 JPWO2023081722A5 JP2024525613A JP2024525613A JPWO2023081722A5 JP WO2023081722 A5 JPWO2023081722 A5 JP WO2023081722A5 JP 2024525613 A JP2024525613 A JP 2024525613A JP 2024525613 A JP2024525613 A JP 2024525613A JP WO2023081722 A5 JPWO2023081722 A5 JP WO2023081722A5
- Authority
- JP
- Japan
- Prior art keywords
- quality control
- nucleosides
- dna
- conversion
- nucleoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163274868P | 2021-11-02 | 2021-11-02 | |
| US63/274,868 | 2021-11-02 | ||
| PCT/US2022/079173 WO2023081722A2 (en) | 2021-11-02 | 2022-11-02 | Quality control method |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024540168A JP2024540168A (ja) | 2024-10-31 |
| JPWO2023081722A5 true JPWO2023081722A5 (https=) | 2025-11-10 |
| JP2024540168A5 JP2024540168A5 (https=) | 2025-11-10 |
Family
ID=84367177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525613A Pending JP2024540168A (ja) | 2021-11-02 | 2022-11-02 | 品質管理方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240093292A1 (https=) |
| EP (1) | EP4426858B1 (https=) |
| JP (1) | JP2024540168A (https=) |
| WO (1) | WO2023081722A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4705514A1 (en) * | 2023-05-01 | 2026-03-11 | Guardant Health, Inc. | Quality control method for enzymatic conversion procedures |
| WO2026072949A1 (en) * | 2024-09-27 | 2026-04-02 | Roche Sequencing Solutions, Inc. | Multi-modal risk stratification of minimum residual disease |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582908B2 (en) | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| US20030017081A1 (en) | 1994-02-10 | 2003-01-23 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
| AU2002359522A1 (en) | 2001-11-28 | 2003-06-10 | Applera Corporation | Compositions and methods of selective nucleic acid isolation |
| CA2519860C (en) | 2003-03-21 | 2018-01-16 | Santaris Pharma A/S | Short interfering rna (sirna) analogues |
| US8835358B2 (en) | 2009-12-15 | 2014-09-16 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse labels |
| GB2533006B (en) | 2012-09-04 | 2017-06-07 | Guardant Health Inc | Systems and methods to detect copy number variation |
| US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| KR102423682B1 (ko) * | 2014-01-07 | 2022-07-20 | 푼다시오 프리바다 인스티튜트 데 메디시나 프레딕티바 이 페르소나리짜다 델 카세르 | 이중 가닥 dna 라이브러리 제공 방법 및 메틸화된 시토신의 확인을 위한 시퀀싱 방법 |
| GB201413318D0 (en) * | 2014-07-28 | 2014-09-10 | Cambridge Epigenetix Ltd | Nucleic acid sample preparation |
| US9850523B1 (en) | 2016-09-30 | 2017-12-26 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| CA3046007A1 (en) | 2016-12-22 | 2018-06-28 | Guardant Health, Inc. | Methods and systems for analyzing nucleic acid molecules |
| EP4567131A3 (en) | 2019-01-31 | 2025-09-03 | Guardant Health, Inc. | Compositions and methods for isolating cell-free dna |
| AU2020283042B2 (en) * | 2019-05-31 | 2026-02-19 | Freenome Holdings, Inc. | Methods and systems for high-depth sequencing of methylated nucleic acid |
| WO2021005537A1 (en) * | 2019-07-08 | 2021-01-14 | The Chancellor, Masters And Scholars Of The University Of Oxford | Bisulfite-free, whole genome methylation analysis |
| US11359238B2 (en) * | 2020-03-06 | 2022-06-14 | Singular Genomics Systems, Inc. | Linked paired strand sequencing |
-
2022
- 2022-11-02 JP JP2024525613A patent/JP2024540168A/ja active Pending
- 2022-11-02 EP EP22814588.4A patent/EP4426858B1/en active Active
- 2022-11-02 WO PCT/US2022/079173 patent/WO2023081722A2/en not_active Ceased
-
2023
- 2023-08-04 US US18/365,744 patent/US20240093292A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102628878B1 (ko) | 메틸롬 분석을 이용한 암 검출 및 분류 | |
| JP2020513801A (ja) | メチル化状態が維持されるdna増幅方法 | |
| JP2023550141A (ja) | 制限酵素及びハイスループット配列決定を用いたdna試料におけるメチル化変化の検出 | |
| Que et al. | Terminal deoxynucleotidyl transferase and rolling circle amplification induced G-triplex formation: a label-free fluorescent strategy for DNA methyltransferase activity assay | |
| Gršković et al. | DNA methylation: the future of crime scene investigation? | |
| WO2024056008A1 (zh) | 鉴别癌症的甲基化标志物及应用 | |
| Tost | Current and emerging technologies for the analysis of the genome-wide and locus-specific DNA methylation patterns | |
| Kumar et al. | Analysis of DNA methylation using pyrosequencing | |
| Wu et al. | GlaI cleavage assistant isothermal exponential amplification coupling with CRISPR/Cas12a for ultrasensitive detection of CLDN11 methylation: A potential marker for lung adenocarcinoma | |
| JPWO2022073012A5 (https=) | ||
| JPWO2021067484A5 (https=) | ||
| KR20240046525A (ko) | 세포-유리 dna에 대한 tet-보조 피리딘 보란 시퀀싱과 관련된 조성물 및 방법 | |
| Kumar et al. | Techniques/tools to study epigenetic biomarkers in human cancer detection | |
| TW201934568A (zh) | 一種用於檢測食道癌的基因標誌物及其用途和檢測方法 | |
| JPWO2023081722A5 (https=) | ||
| CN114206895A (zh) | 用于检测dna中n-4-乙酰基脱氧胞苷的方法和试剂盒 | |
| Dai et al. | Ultrasensitive amplification-free quantification of a methyl CpG-rich cancer biomarker by single-molecule kinetic fingerprinting | |
| Zhou et al. | HOGG1-assisted DNA methylation analysis via a sensitive lanthanide labelling strategy | |
| CN117778568A (zh) | 鉴别胃癌的标志物及应用 | |
| JPWO2022115810A5 (https=) | ||
| US20250361549A1 (en) | Detection of epigenetic cytosine modification | |
| WO2026050179A1 (en) | Tumor fraction (tf) is associated with real-world progression-free survival (rwpfs) in non-small-cell lung cancer (nsclc) patients treated with platinum-based chemotherapy (chemo) | |
| US20250308636A1 (en) | Inferring cnvs from the distribution of molecules in hyper partition | |
| US20250218587A1 (en) | Methods and systems for identifying tumor origin | |
| JPWO2022271730A5 (https=) |